1. Higher serum PD‐L1 level predicts increased overall survival with lapatinib versus trastuzumab in the CCTG MA.31 phase 3 trial. Issue 22 (10th September 2020) Authors: Moku, Prashanth; Shepherd, Lois; Ali, Suhail M.; Leitzel, Kim; Parulekar, Wendy R.; Zhu, Liting; Virk, Shakeel; Nomikos, Dora; Aparicio, Samuel; Gelmon, Karen; Drabick, Joe; Cream, Leah; Halstead, E. Scott; Umstead, Todd M.; Mckeone, Dan; Polimera, Hyma; Maddukuri, Ashok; Ali, Aamnah; Nagabhairu,... Journal: Cancer Issue: Volume 126:Issue 22(2020) Page Start: 4859 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗